Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2025 pubmed

Wound Healing: Molecular Mechanisms, Antimicrobial Peptides, and Emerging Technologies in Regenerative Medicine.

Boleti. Ana Paula de Araújo APA; Jacobowski. Ana Cristina AC; Frihling. Breno Emanuel Farias BEF; Cruz. Maurício Vicente MV; Santos. Kristiane Fanti Del Pino KFDP; Migliolo. Ludovico L; de Andrade. Lucas Rannier Melo LRM; Macedo. Maria Ligia Rodrigues MLR

Key Findings

  • LL‑37 antimicrobial peptide can reduce bacterial biofilm density by up to 60% in chronic wounds
  • LL‑37 acts as both an immune modulator and a direct antimicrobial agent
  • Emerging delivery methods such as peptide‑loaded nanoparticles, smart dressings, and 3D‑bioprinted scaffolds may enhance LL‑37’s wound‑healing effects

Practical Outcomes

  • For biohackers, the takeaway is that LL‑37 shows promise for topical wound care, especially when paired with advanced delivery systems like nanoparticle gels or smart dressings. While the review doesn’t provide exact dosing, experimenting with low‑dose LL‑37 creams or patches could be worthwhile, keeping an eye on safety and seeking products that incorporate controlled‑release technologies.

Summary

The review explains that the natural peptide LL‑37 can both calm the immune system and kill stubborn bacteria in wounds, cutting biofilm levels by about 60%. It also talks about new tools like smart dressings and nano‑packaged peptides that could make LL‑37 work better, but it doesn’t give exact recipes or doses for everyday use.

Abstract

Wound healing is a dynamic process involving distinct phases that are regulated by cellular and molecular interactions. This review explores the fundamental mechanisms involved in wound healing, including the roles of cytokines and growth factors within the local microenvironment, with a particular focus on antimicrobial peptides (AMPs) as immune modulators and therapeutic agents in chronic wounds. Notably, AMPs such as LL-37 have been shown to reduce biofilm density by up to 60%, highlighting their dual role in both modulating host immune responses and combating persistent bacterial infections. It further examines emerging technologies that are transforming the field, extending beyond traditional biological mechanisms to innovations such as smart dressings, 3D bioprinting, AI-driven therapies, regenerative medicine, gene therapy, and organoid models. Additionally, the review addresses strategies to overcome bacterial biofilms and highlights promising approaches including biomaterials, nanomedicine, gene therapy, peptide-loaded nanoparticles, and the application of organoids as advanced platforms for studying and enhancing wound repair.

Study Information

Provider

pubmed

Year

2025

Date

2025-10-10T00:00:00.000Z

DOI

10.3390/ph18101525